Prenetics Global (NASDAQ:PRENW – Get Free Report) is anticipated to release its results before the market opens on Thursday, November 5th. Analysts expect Prenetics Global to post earnings of ($0.82) per share and revenue of $63.28 million for the quarter.
Prenetics Global Trading Down 9.2%
Shares of PRENW stock opened at $0.01 on Thursday. The company has a fifty day moving average price of $0.01 and a two-hundred day moving average price of $0.02. Prenetics Global has a one year low of $0.01 and a one year high of $0.03.
Prenetics Global Company Profile
Prenetics Global Limited is a health sciences and diagnostics company focused on genomics, precision oncology and consumer health. The company develops and commercializes genetic testing, diagnostic and personalized health solutions designed to help individuals and healthcare providers better understand disease risk and support more informed treatment and wellness decisions.
Its offerings have included CircleDNA, a direct-to-consumer genetic testing platform that provides reports related to health, wellness, nutrition and ancestry, as well as clinical genomic services.
See Also
- Five stocks we like better than Prenetics Global
- Why Rising Rates Could Break the Bull Market Before AI Spending Can Save It
- Boeing Got Its MAX 10 Approval, But Q3 Delivered a Reality Check
- The Invisible AI Backbone: Corning’s AI Fiber Play
- Heavy Metal: Why Nucor Could Be an Overlooked AI Infrastructure Winner
Receive News & Ratings for Prenetics Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prenetics Global and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png){kind=logo}
